Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer
- 40 Downloads
Preoperative diagnostic interventions such as transbronchial biopsy and/or computed tomography-guided biopsy inevitably disrupt the lung structures and may disseminate tumour cells into the airway, vessels, or pleural cavity. Therefore, these procedures may affect the postoperative outcomes. Thus, we aimed to compare the survival outcomes in patients diagnosed by transbronchial biopsy vs computed tomography-guided biopsy vs lung resection.
In a single-institution retrospective analysis, data from consecutive patients with cTanyN0M0 lung cancer, who underwent surgery between January 2006 and December 2012, were extracted by chart review. The overall and recurrence-free survivals of patients diagnosed by transbronchial biopsy, computed tomography-guided biopsy, and lung resection were compared using the univariate and multivariate Cox proportional hazard models. A stepwise backward elimination method, with a probability level of 0.15, was used to select the most powerful sets of outcome predictors.
Transbronchial biopsy and/or computed tomography-guided biopsy were performed for larger and more advanced tumours, than lung resection (intra- or postoperative-diagnosis group). At crude analysis, transbronchial biopsy group and computed tomography-guided biopsy group showed higher probability of pleural dissemination, and worse prognosis than the lung resection group. At multivariate analysis, the diagnostic methods were not identified as independent risk factors of pleural dissemination, overall survival, or recurrence-free survival.
Preoperative diagnostic interventions did not affect the relapse risk and prognosis, in this study cohort. Thus, preoperative diagnostic intervention is recommended if deemed necessary.
KeywordsPreoperative diagnostic Transbronchial biopsy Computed tomography-guided biopsy Multivariate analysis Non-small cell lung cancer
We thank Mr. Hideyuki Kozuka and Ms. Tomoko Hasegawa for their assistance in data collection and Mr. Tomoki Kitawaki and Mr. Takayuki Kawaura for their assistance in data-analysis.
Compliance with ethical standards
Conflict of interest
All authors have no conflict of interest.
- 6.Sobin LH, Gospodarowicz MK, Wittekind C. Lung and pleural tumours. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell, 2009. pp. 138–46.Google Scholar
- 7.Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. In: Kleihues P, Sobin LH (eds) World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer press; 2004. pp. 9–124.Google Scholar
- 8.Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016;11:1204–23.CrossRefGoogle Scholar
- 11.Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, et al. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg. 2012;143:607–12.CrossRefGoogle Scholar
- 15.Shields TW, LoCicero J, Reed CE, Feins RH. Chapter 15 Laboratory Investigations in the diagnosis of pulmonary diseases. In: Robinson PG. General thoracic surgery. Philadelphia: Lippincott Williams & Wilkins; 2009. pp. 237–64.Google Scholar
- 16.Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143: e142S-e165S.Google Scholar
- 24.Sawabata N, Funaki S, Hyakutake T, Shintani Y, Fujiwara A, Okumura M. Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood? Surg Today. 2016;46:1402–9.CrossRefGoogle Scholar